Medical Management of Coronary Heart Disease: Cardiovascular Drug Therapy

American Heart Association. (1983). Heart facts. Dallas: author.

Antman E. Stone P. Muller J. Braunwald E. (1980). Calcium channel blocking agents in the treatment of cardiovascular disorders. Part 1: Basic and clinical electrophysiologic effects. Annals of Internal Medicine, 93, 875–885.

Berne R. Rubio R. (1979). Coronary circulation (vol. 1, pp. 873–952), In Handbook of physiology. Baltimore: The Williams & Wilkens Co.

Brunton T.L. (1867). On the use of nitrate of amyl in angina pectoris. Lancet, 2, 97.

Cohn P. Braunwald E. (1980). Chronic coronary artery disease (pp. 1387–1436). In Braunwald E. (Ed.), Heart disease. Philadelphia: W.B. Saunders.

Frishman W. (1983). Drug therapy: Pindolol: A new β-adrenoreceptor antagonist with partial agonist activity. New England Journal of Medicine, 308, 940–944.

Norwegian Multicenter Study Group. (1981). Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. New England Journal of Medicine, 304, 801–807.

Stone P. (1982). Use of the calcium channel blocking agents in the treatment of chronic stable angina pectoris. Cardiovascular Review and Report, 3, 39–53.

Stone P. (1983). Use of the calcium channel blocking agents to salvage ischemic myocardium (pp. 209–223), In Calcium antagonists: The state of the art and role in cardiovascular disease. Philadelphia: American College of Clinical Pharmaceuticals.

Stone P. Antman E. Muller J. Braunwald E. (1980). Calcium Channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. Annals of Internal Medicine, 93, 886–904.

Zacharias R. Cowen K. Prestt J. Vickers J. Wall B. (1972). Propranolol in hypertension: A study of long-term therapy, 1964–1970. American Heart Journal, 83, 775.